Glenmark Pharmaceuticals Limited Share Price Bombay S.E.
Stocks
GLENMARK
INE935A01035
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,295.05 INR | -0.45% |
|
+3.20% | +12.73% |
| 07-07 | India finds Adani's Mumbai airport shops sold nicotine pouches in breach of law | RE |
| 07-06 | Glenmark Pharmaceuticals Launches Olanzapine for Injection | MT |
| Market Cap | 651B 6.77B 5.92B 5.47B 5.05B 9.52B 9.69B 65.24B 25.6B 319B 25.44B 24.88B 1,097B | P/E 2026 |
44.2x | P/E 2027 * | 27.7x |
|---|---|---|---|---|---|
| Enterprise Value | 611B 6.36B 5.56B 5.14B 4.75B 8.94B 9.11B 61.3B 24.05B 299B 23.9B 23.37B 1,031B | EV / Sales 2026 |
3.51x | EV / Sales 2027 * | 3.68x |
| Free-Float |
51.03% | Yield 2026 |
0.12% | Yield 2027 * | 0.23% |
Last Transcript: Glenmark Pharmaceuticals Limited
| 1 day | -0.45% | ||
| 1 week | +3.20% | ||
| Current month | +4.09% | ||
| 1 month | +6.47% | ||
| 3 months | +1.54% | ||
| 6 months | +14.72% | ||
| Current year | +12.73% |
| 1 week | 2,224.65 |  | 2,326 |
| 1 month | 2,109 | | 2,326 |
| Current year | 1,842.8 | | 2,471.05 |
| 1 year | 1,794 | | 2,471.05 |
| 3 years | 695.55 | | 2,471.05 |
| 5 years | 348.9 | | 2,471.05 |
| 10 years | 168 | | 2,471.05 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 31/12/1999 | |
Anurag Mantri
DFI | Director of Finance/CFO | 54 | 26/05/2025 |
Indrajit Bose
PSD | President | - | 14/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Cherylann Pinto
BRD | Director/Board Member | 58 | - |
| Chairman | 56 | 11/05/2011 | |
| Director/Board Member | 85 | 13/08/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.45% | +3.20% | - | - | 6.77B | |
| +0.46% | +3.35% | +12.97% | +81.10% | 48.52B | |
| -0.36% | -1.79% | +66.39% | +111.26% | 35.68B | |
| -0.01% | +0.43% | -3.55% | +39.25% | 12.09B | |
| +2.06% | +0.78% | +19.56% | +91.84% | 11.77B | |
| +1.32% | +0.38% | +32.83% | +126.50% | 9.19B | |
| -1.81% | -4.04% | +43.76% | -5.22% | 7.06B | |
| -0.91% | -0.83% | +17.92% | +36.43% | 7.01B | |
| +3.56% | -6.15% | -20.01% | +13.39% | 5.98B | |
| +1.33% | +5.35% | +28.04% | +140.96% | 4.43B | |
| Average | +0.51% | -0.44% | +21.99% | +70.61% | 15.75B | |
| Weighted average by Cap. | +0.34% | -0.64% | +27.70% | +81.46% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 153B 1.59B 1.39B 1.29B 1.19B 2.24B 2.28B 15.36B 6.03B 74.97B 5.99B 5.86B 258B | 167B 1.74B 1.52B 1.4B 1.3B 2.44B 2.48B 16.72B 6.56B 81.64B 6.52B 6.38B 281B |
| Net income | 20.53B 214M 187M 173M 160M 300M 306M 2.06B 808M 10.05B 803M 785M 34.62B | 23.28B 242M 212M 196M 181M 341M 347M 2.34B 916M 11.4B 910M 890M 39.26B |
| Net Debt | -39.29B -409M -357M -330M -305M -575M -585M -3.94B -1.55B -19.24B -1.54B -1.5B -66.25B | -37.12B -386M -338M -312M -288M -543M -553M -3.72B -1.46B -18.18B -1.45B -1.42B -62.59B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/07/26 | ₹2,295.05 | -0.45% | 11,270 |
| 14/07/26 | ₹2,305.50 | +0.18% | 16,573 |
| 13/07/26 | ₹2,301.40 | +0.84% | 19,902 |
| 10/07/26 | ₹2,282.25 | +0.75% | 9,745 |
| 09/07/26 | ₹2,265.25 | +1.86% | 22,069 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLENMARK Stock
- GLENMARK Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
